CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Other Non-Current Liabilities (2023 - 2026)

Updated

CytoMed Therapeutics (GDTC) posted Other Non-Current Liabilities of $19,339 for Q4 2025, up 115.4% from $8,980 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, CytoMed Therapeutics' Other Non-Current Liabilities came in at $19,184, up 114.5% from FY2024.

  • In prior years, CytoMed Therapeutics' Other Non-Current Liabilities was $8,942 in FY2024 (-91.8%) and $109,199 in FY2023.
  • Quarterly Other Non-Current Liabilities has run from a low of $8,980 in Q4 2024 to a high of $108,595 in Q4 2023 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,698.00
Dec 31, 2025 19,338.83
Jun 30, 2025 88,268.00
Dec 31, 2024 8,979.97
Dec 31, 2023 108,595.14
API Access

CytoMed Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=GDTC&period=max&api_key=YOUR_API_KEY